
. General Information
LARIGO DS 500 MG is an antimalarial medicine containing chloroquine phosphate 500 mg. It is used for the treatment and, in selected circumstances, prevention of malaria caused by susceptible malaria parasites. The medicine works against the parasite responsible for malaria and helps stop the infection from progressing.
LARIGO DS 500 MG is available as an oral tablet and is associated with Ipca Laboratories Ltd. in Indian product listings.
Phoenix Exim is a medicine exporter from Nagpur, India, serving pharmaceutical supply requirements for the USA, UK, Australia, Singapore, Canada, South Korea and UAE.
2. Product Information
- Brand: LARIGO DS 500 MG
- Generic name: Chloroquine
- Active ingredient: Chloroquine phosphate
- Strength: 500 mg
- Dosage form: Tablet
- Therapeutic category: Antimalarial / antiparasitic medicine
- Manufacturer: Ipca Laboratories Ltd.
- Primary indication: Malaria
- Route: Oral administration
- Packaging: Commonly supplied in strips; pack sizes may vary by market.
3. Uses of LARIGO DS 500 MG
LARIGO DS 500 MG is primarily used for the treatment of malaria when the causative parasite is susceptible to chloroquine. Depending on local resistance patterns and medical guidance, chloroquine may also have other specific medical applications.
It should not be assumed to be effective against every type of malaria because chloroquine resistance is widespread in some malaria parasites and geographic regions. Treatment should therefore be selected by a qualified healthcare professional.
4. Benefits of LARIGO DS 500 MG
- Helps treat susceptible malaria infections.
- Acts directly against malaria parasites.
- Can help reduce malaria-related symptoms such as fever and chills when the infection responds to treatment.
- Oral tablet formulation makes administration convenient.
- Established antimalarial medicine with chloroquine as its active ingredient.
5. Side Effects of LARIGO DS 500 MG
Like other medicines, LARIGO DS 500 MG may cause side effects. Possible adverse effects include:
- Nausea
- Vomiting
- Stomach discomfort or abdominal pain
- Diarrhea
- Headache
- Dizziness
- Skin rash
- Loss of appetite
- Blurred vision
Most mild effects may improve as the body adjusts to treatment. Persistent or severe symptoms should be discussed with a healthcare professional.
6. Common Side Effects
Some commonly reported effects include:
- Nausea
- Vomiting
- Headache
- Dizziness
- Abdominal discomfort
- Diarrhea
- Skin rash
- Loss of appetite
Long-term or inappropriate use can increase the risk of more serious effects, including eye-related problems, so prolonged treatment should be medically supervised.
7. How to Use LARIGO DS 500 MG
Take LARIGO DS 500 MG only in the dose and for the duration prescribed by your doctor. Swallow the tablet with water. Taking it with food may help reduce stomach irritation. Do not crush or chew the tablet unless your healthcare professional specifically instructs you to do so.
The correct dosage and treatment duration depend on the type of malaria, the patient's age and weight, local resistance patterns, and other medical factors. Do not self-medicate for suspected malaria.
If you miss a dose, take it when remembered unless it is nearly time for the next dose. Do not take a double dose.
8. How LARIGO DS 500 MG Works
Chloroquine interferes with the malaria parasite's ability to process haemoglobin inside infected red blood cells. This leads to accumulation of toxic substances within the parasite and ultimately damages or kills the parasite, helping control the malaria infection.
9. Safety Advice
Pregnancy: Use only when recommended by a healthcare professional. The potential benefits and risks should be assessed individually.
Breastfeeding: Tell your doctor if you are breastfeeding before starting treatment.
Kidney problems: Dose adjustment or additional monitoring may be required in people with kidney disease.
Liver problems: Inform your doctor about liver disease because monitoring or dosage adjustment may be necessary.
Eyes: Chloroquine can cause visual problems, particularly with prolonged use. Report blurred vision, difficulty focusing, or other visual changes promptly.
Driving: Avoid driving or operating machinery if the medicine causes dizziness or visual disturbances.
Drug interactions: Inform your doctor about all medicines, supplements, and herbal products you are taking before starting chloroquine.
Important: Chloroquine should only be used for malaria when the parasite is known or expected to be susceptible. It should not be substituted for another antimalarial without professional advice.
10. FAQs
Q1. What is LARIGO DS 500 MG used for?
LARIGO DS 500 MG is an antimalarial medicine containing chloroquine phosphate 500 mg and is used to treat susceptible malaria infections.
Q2. What is the active ingredient in LARIGO DS 500 MG?
It contains chloroquine phosphate, providing a 500 mg strength as listed for Lariago-DS products.
Q3. Can I take LARIGO DS without a prescription?
Malaria can become serious quickly. Treatment should be based on appropriate medical evaluation and professional advice rather than self-medication.
Q4. Can LARIGO DS prevent malaria?
Chloroquine can be used for prevention in selected situations where malaria parasites remain chloroquine-sensitive, but suitability depends on the destination and resistance patterns. A healthcare professional should advise on malaria prevention.
Q5. Can I stop treatment when I feel better?
No. Follow the prescribed course and do not stop treatment early unless instructed by your healthcare professional.
Q6. Can LARIGO DS cause vision problems?
Yes. Visual disturbances can occur, particularly with prolonged exposure. Any new or unexplained visual symptoms should be reported to a doctor.
Q7. What should I do if I miss a dose?
Take it when remembered unless it is close to the next scheduled dose. Never double the dose.
Q8. Is LARIGO DS suitable for severe malaria?
Severe malaria requires urgent medical treatment and may require injectable or other specialized antimalarial therapy. Do not rely on oral LARIGO DS for severe malaria.
11. Substitute for LARIGO DS 500 MG
Possible alternatives depend on the malaria parasite, geographic resistance pattern, patient factors, and treatment guidelines. Chloroquine 500 mg products from another manufacturer may be pharmaceutical equivalents where appropriate, but they should not automatically be considered interchangeable for every malaria infection.
Other antimalarial medicines such as artemether/lumefantrine, artesunate-based therapies, mefloquine, or atovaquone/proguanil may be used in particular circumstances, but the appropriate choice must be determined by a qualified healthcare professional.
12. SEO Keywords
- LARIGO DS 500 MG tablets
- LARIGO DS 500 MG exporter India
- Chloroquine phosphate 500 mg tablets
- Chloroquine tablets exporter from India
- Antimalarial medicine supplier India
- Malaria medicine exporter India
- LARIGO DS medicine supplier
- Chloroquine phosphate tablets supplier
- Genuine LARIGO DS 500 MG
- LARIGO DS wholesale exporter
- Indian antimalarial medicine supplier
- Malaria treatment tablets exporter
- Pharmaceutical exporter Nagpur India
- LARIGO DS 500 MG wholesale supply
- Chloroquine 500 mg pharmaceutical supplier
- Antiparasitic medicine exporter India
- LARIGO DS tablets global supply
- Malaria medicine wholesale supplier
- Chloroquine phosphate medicine exporter
- LARIGO DS 500 MG pharmaceutical export
- Indian pharma supplier for malaria medicines
- LARIGO DS export to USA
- LARIGO DS export to UK
- LARIGO DS export to Australia
- LARIGO DS export to Canada
- LARIGO DS export to Singapore
- LARIGO DS export to South Korea
- LARIGO DS export to UAE
- Trusted Indian pharmaceutical exporter
- Phoenix Exim LARIGO DS supplier
- Phoenix Exim medicine exporter India
- Bulk antimalarial tablets supplier
- Chloroquine tablets bulk exporter
- Genuine Indian pharmaceutical products
- Global pharmaceutical export supplier
Keywords







